CClassifation of CannabisPublic classificationby Justin Strekal, NORML Political Director
October 16, 2018
Comments
The US Food and Drug Administration is seeking public comments specific to whether changes ought to be recommended regarding the international classification of cannabis as a controlled substance. Members of the public have until October 31, 2018 to submit their comments to the FDA for consideration.
The FDA says that the comments “will be considered in preparing a response from the United States to the World Health Organization regarding the abuse liability and diversion” of marijuana and certain other substances.
In April, in response to a similar FDA request, NORML collected and hand-delivered over 10,000 comments to the agency calling on it to recommend a lifting of international restrictions criminalizing the plant. In total, comments from NORML members totaled over 60% of the public comments submitted nationwide.
Click here to submit a public comment NOW
In NORML’s latest comments to the FDA, it opined that “cannabis be removed from the international drug conventions so that nations that wish to do so may further expand their regulations governing cannabis’ use, possession, production, and dispensing for either recreational or medical use.”
Let’s continue to dominate the debate. Click here to submit your own public comment now.
Then take the next step:
Share our Action Alert on Twitter
Share our Action Alert on Facebook
Posted in : ACTIVISM, Advocacy, Citizen Lobbyists, GOVERNMENT, Policy
Add Your Comment
Do your part to
help legalize marijuana! (how?)
Act!
Donate
Lawyers
Shop
NORML Newsletter
FDA Seeks Public Comments Regarding International Classification Of Cannabis
October 17, 2018
CClassifation of CannabisPublic classificationby Justin Strekal, NORML Political Director
October 16, 2018
Comments
The US Food and Drug Administration is seeking public comments specific to whether changes ought to be recommended regarding the international classification of cannabis as a controlled substance. Members of the public have until October 31, 2018 to submit their comments to the FDA for consideration.
The FDA says that the comments “will be considered in preparing a response from the United States to the World Health Organization regarding the abuse liability and diversion” of marijuana and certain other substances.
In April, in response to a similar FDA request, NORML collected and hand-delivered over 10,000 comments to the agency calling on it to recommend a lifting of international restrictions criminalizing the plant. In total, comments from NORML members totaled over 60% of the public comments submitted nationwide.
Click here to submit a public comment NOW
In NORML’s latest comments to the FDA, it opined that “cannabis be removed from the international drug conventions so that nations that wish to do so may further expand their regulations governing cannabis’ use, possession, production, and dispensing for either recreational or medical use.”
Let’s continue to dominate the debate. Click here to submit your own public comment now.
Then take the next step:
Share our Action Alert on Twitter
Share our Action Alert on Facebook
Posted in : ACTIVISM, Advocacy, Citizen Lobbyists, GOVERNMENT, Policy
Add Your Comment
Do your part to
help legalize marijuana! (how?)
Act!
Donate
Lawyers
Shop
NORML Newsletter
Search
RECENT PRESS RELEASES
Big Investors Still Supportive of Sustainable Investing
SWI Editorial StaffJune 9, 2025|
Renn fund president Murray Stahl acquires $3,358 in stock By Investing.com
SWI Editorial StaffJune 9, 2025|
Earnings call transcript: Graham Corporation beats Q3 2025 forecasts By Investing.com
SWI Editorial StaffJune 9, 2025|
Clean Harbors co-CEO sells $1.82 million in stock By Investing.com
SWI Editorial StaffJune 9, 2025|
Bitcoin Breaks Above $108,000 While Ethereum Inflows Surge
SWI Editorial StaffJune 9, 2025|
ASTS Short Interest Declines as Shares Surge Amid Speculation
SWI Editorial StaffJune 9, 2025|
Related Post
Bitcoin hovers above $108,000, but analysts warn against the next BTC drop
Why it’s high time we changed the law on cannabis
Meta Splits Its AI Division Into Product And AGI Teams To Speed Up Development, Enhance Co
Can Ethereum Price Break $5K and Hit New All-time High in 2025